Latin America & Caribbean vs Nicaragua: Immunization, measles second dose
Latin America & Caribbean
69.3%
in 2024
Nicaragua
95.0%
in 2023
Latin America & Caribbean rank
31st
Nicaragua rank
33rd
Immunization, measles second dose over time
- Latin America & Caribbean
- Nicaragua
How they compare
Nicaragua currently reports 95.0% against 69.3% in Latin America & Caribbean, a difference of 25.7%.
That makes Nicaragua's figure about 1.4 times Latin America & Caribbean's.
Across all 7 years both countries report, Nicaragua has been ahead every year.
Latin America & Caribbean ranks 31st and Nicaragua ranks 33rd of 43 groups.
Nicaragua has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latin America & Caribbean | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 69.8% | 92.7% | 22.9% | Nicaragua |
| 2020s | 66.9% | 93.8% | 26.8% | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Latin America & Caribbean or Nicaragua?
- Nicaragua, at 95.0% against 69.3% in Latin America & Caribbean as of 2023.
- What is the difference in immunization, measles second dose between Latin America & Caribbean and Nicaragua?
- 25.7%, with Nicaragua ahead.
- How many years of comparable data are there for Latin America & Caribbean and Nicaragua?
- 7 years are reported by both, from 2017 to 2023.
- How do Latin America & Caribbean and Nicaragua rank globally for immunization, measles second dose?
- Latin America & Caribbean ranks 31st and Nicaragua ranks 33rd of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.